The Vanguard Group, Inc. recently announced the acquisition of new stake in Boeing Co. (NYSE:BA). The institutional investor has increased its shareholding in the Industrials company by 0.72% to 45.39 million shares with purchase of 0.33 million shares. This fresh investment now brings its stake to 7.50% valued currently at $11.83 billion. In addition, BlackRock Fund Advisors raised its holdings by 24835.0 to 28.31 million shares. And Capital Research & Management Co has lifted its position by 12.05% or 1.34 million shares – to 12.45 million shares.
Currently, there are 604.98M common shares owned by the public and among those 604.04M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 28 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, accounting for 195,257 shares. Insider sales of the common stock occurred on 13 occasions, with total insider shares sold totaling 23,629 shares.
The top 3 mutual fund holders in Boeing Co. are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and American Funds Growth Fund of Ame. Vanguard Total Stock Market ETF owns 19.0 million shares of the company’s stock, all valued at over $4.95 billion. The company bought an additional 88958.0 shares recently to bring their total holdings to about 3.14% of the shares outstanding. Vanguard 500 Index Fund bought 66802.0 shares to see its total holdings expand to 13.89 million shares valued at over $3.62 billion and representing 2.30% of the shares outstanding. American Funds Growth Fund of Ame bought 2.06 million shares to bring its total holdings to over 9.23 million shares at a value of $2.4 billion. American Funds Growth Fund of Ame now owns shares totaling to 1.53% of the shares outstanding.
However, the script later moved the day high at 206.75, up 1.78%. The company’s stock has a 5-day price change of -4.44% and 15.61% over the past three months. BA shares are trading -21.17% year to date (YTD), with the 12-month market performance down to -3.39% lower. It has a 12-month low price of $176.25 and touched a high of $267.54 over the same period. BA has an average intraday trading volume of 8.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -10.05%, -11.71%, and -4.12% respectively.
Institutional ownership of Boeing Co. (NYSE: BA) shares accounts for 62.57% of the company’s 604.98M shares outstanding. Mutual fund holders own 30.01%, while other institutional holders and individual stakeholders account for 32.73% and 0.93% respectively.
It has a market capitalization of $124.31B and a beta (3y monthly) value of 1.54. The earnings-per-share (ttm) stands at -$4.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.18% over the week and 2.80% over the month.
Analysts forecast that Boeing Co. (BA) will achieve an EPS of $Bank of America Corporation for the current quarter, $33.43 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $CBL Nature-Based Global Emissio while analysts give the company a high EPS estimate of $BAM/RSD. Comparatively, EPS for the current quarter was $E-mini S&P Regional Banks Selec a year ago. Earnings per share for the fiscal year are expected to increase by 46.13%, and 168.26% over the next financial year.
Looking at the support for the BA, a number of firms have released research notes about the stock. BofA Securities stated their Neutral rating for the stock in a research note on January 25, 2024, with the firm’s price target at $255-$225.
